Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. New Zealand
  4. New Zealand Stock Exchange
  5. Fisher & Paykel Healthcare Corporation Limited
  6. Summary
    FPH   NZFAPE0001S2

FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED

(FPH)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote New Zealand Stock Exchang…
05/11/2022 05/12/2022 05/13/2022 05/16/2022 05/17/2022 Date
20.9 20.35 21.05 21.05 20.78 Last
812307 743597 453322 300081 421405 Volume
-1.69% -2.63% +3.44% 0.00% -1.28% Change
Estimated financial data (e)
Sales 2022 1 705 M 1 082 M 1 082 M
Net income 2022 379 M 240 M 240 M
Net cash position 2022 184 M 117 M 117 M
P/E ratio 2022 31,8x
Yield 2022 1,88%
Sales 2023 1 631 M 1 035 M 1 035 M
Net income 2023 341 M 216 M 216 M
Net cash position 2023 192 M 122 M 122 M
P/E ratio 2023 35,8x
Yield 2023 1,93%
Capitalization 11 996 M 7 614 M 7 614 M
EV / Sales 2022 6,93x
EV / Sales 2023 7,24x
Nbr of Employees 5 811
Free-Float 93,5%
More Financials
Company
Fisher & Paykel Healthcare Corporation Limited designs, manufactures and markets medical device products and systems for use in respiratory care, acute care, surgery and the treatment of obstructive sleep apnea. The Company’s segment includes North America, which includes all activities controlled by entities or employees based in the United States and Canada; Europe, which includes all activities controlled by... 
Read more
More about the company
Ratings of Fisher & Paykel Healthcare Corporation Limited
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
A-
More Ratings
All news about FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED
04/20FISHER & PAYKEL HEALTHCARE ANNOUNCES : Fisher & Paykel Healthcare announces USA launch of ..
PU
04/19FISHER & PAYKEL HEALTHCARE : Application for quotation of securities - FPH
PU
04/13FISHER & PAYKEL HEALTHCARE : announces 2022 Investor Day
PU
04/13FISHER & PAYKEL HEALTHCARE : to announce full year results on 25 May 2022
PU
04/07FISHER & PAYKEL HEALTHCARE : Application for quotation of securities - FPH
PU
03/24UBS Adjusts Fisher & Paykel Healthcare's Price Target to NZ$21.90 From NZ$23.50, Keeps ..
MT
03/23Australian shares end at 2-month high on tech, banking boost
RE
03/22Australian shares extend gains to 2-month high on banking, tech boost
RE
03/22Fisher & Paykel Healthcare Corporation Limited Provides Revenue Guidance for the Financ..
CI
03/22FISHER & PAYKEL HEALTHCARE : provides FY22 revenue guidance
PU
03/06FISHER & PAYKEL HEALTHCARE : Disclosure Document
PU
02/28FISHER & PAYKEL HEALTHCARE : Application for quotation of securities - FPH
PU
02/21FISHER & PAYKEL HEALTHCARE : Notification of cessation of securities - FPH
PU
02/17FISHER & PAYKEL HEALTHCARE : Notification of cessation of securities - FPH
PU
01/23FISHER & PAYKEL HEALTHCARE : Application for quotation of securities - FPH
PU
More news
News in other languages on FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED
03/22Fisher & Paykel Healthcare Corporation Limited fournit des prévisions de revenus pour l..
2021Fisher & Paykel Healthcare Corporation Limited approuve un dividende intérimaire, payab..
2021Fisher & Paykel lance un masque intégral pour l'apnée du sommeil
2021Fisher & Paykel Healthcare Corporation Limited ne fournit pas de prévisions financières..
2021Fisher & Paykel Healthcare Corporation Limited déclare un dividende ordinaire pour les ..
More news
Analyst Recommendations on FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED
More recommendations
Chart FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED
Duration : Period :
Fisher & Paykel Healthcare Corporation Limited Technical Analysis Chart | FPH | NZFAPE0001S2 | MarketScreener
Technical analysis trends FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 10
Last Close Price 20,78 NZD
Average target price 26,32 NZD
Spread / Average Target 26,7%
EPS Revisions
Managers and Directors
Lewis George Gradon General Manager-Research & Development
Lyndal York Chief Financial Officer
Scott Andrew St. John Chairman
Andrew Robert Donald Somervell Vice President-Products & Technology
Nicholas Fourie VP-Information & Communication Technology
Sector and Competitors
1st jan.Capi. (M$)
FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED-36.57%7 614
ABBOTT LABORATORIES-18.62%200 553
MEDTRONIC PLC2.72%142 552
BECTON, DICKINSON AND COMPANY4.27%73 051
BAXTER INTERNATIONAL INC.-13.40%37 432
HOYA CORPORATION-26.45%35 518